Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: Localization of an upstream transcriptional silencer

Blood

Volumn 88, Issue 10, 1996, Pages 3686-3697

  Antalis, Toni M ^a,b   Costelloe, Elaine ^a   Muddiman, Julie ^a   Ogbourne, Steven ^a   Donnan, Karen ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR INHIBITOR 2; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; HUMAN CELL; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; REGULATOR GENE; REGULATORY MECHANISM; SILENCER GENE; TRANSCRIPTION REGULATION;

EID: 0029803572     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3686.bloodjournal88103686     Document Type: Article

References (43)

1. Stein PE, Carrell RW: What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 2:96, 1995
2. Golder JP, Stephens RW: Minactivin: A human monocyte product which specifically inactivates urokinase-type plasminogen activators. Eur J Biochem 139:253, 1984
3. Kawano T, Morimoto K, Uemura Y: Partial purification and properties of urokinase inhibitor from human placenta. J Biochem 67:333, 1970
4. Danø K, Andreason PA, Grondahl Hansen J, Kristensen P, Neilsen LS, Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139, 1985
5. Dickinson JL, Bates EJ, Ferrante A, Antalis TM: Plasminogen activator inhibitor-type 2 inhibits TNFα-induced apoptosis: Evidence for an alternate biological function. J Biol Chem 270:27894, 1995
6. Kumar S, Baglioni C: Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J Biol Chem 266:20960, 1991
7. Gan HX, Newman GW, Remold HG: Plasminogen activator inhibitor type-2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, Serovar 4. J Immunol 155:1304, 1995
8. Michel JB, Quertermous T: Modulation of mRNA levels for urinary and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1. J Immunol 143:890, 1989
9. Kruithof EKO, Vassali J-D, Schleuning W-D, Mattaliano RS, Bachmann F: Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U937. J Biol Chem 261:11207, 1986
10. Schwartz BS, Monroe MC, Levin EG: Increased release of plasminogen activator inhibitor-2 accompanies the human mononuclear cell response to lipopolysaccharide. Blood 71:734, 1988
11. Ritchie H, Jamieson A, Booth NA: Peripheral blood monocyte synthesis of plasminogen activator inhibitor 2 in respnse to native and modified LDL. Thromb Haemost 74:1521, 1995
12. Haj MA, Robbie LA, Adey GD, Bennett B: Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients. Thromb Haemost 74:1528, 1995
13. Scherrer A, Kruithof EKO, Grob JP: Plasminogen activator inhibitor-2 in patients with monocytic leukemia. Leukemia 5:479, 1991
14. Feinberg RF, Kao LC, Haimowitz JE, Queenan JT, Wun T-C, Strauss JF, Klinan HJ: Plasminogen activator inhibitors types 1 and 2 in human trophoblasts. Lab Invest 61:20, 1989
15. Hashimoto K, Wun T-C, Baird J, Lazarus GS, Jensen PJ: Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acontholysis by purified plasminogen activator inhibitor. Invest Dermatol 92:310, 1989
16. Kruithof EKO, Baker MS, Bunn CL: Biological and clinical aspects of plasminogen activator inhibitor type-2. Blood 86:4007, 1995
17. Antalis TM, Dickinson JL: Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells. Eur J Biochem 205:203, 1992
18. Medcalf RL, Kruithof EKO, Schleuning W-D: Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin responsive genes. J Exp Med 168:751, 1988
19. Kruithof EKO, Cousin E: Plasminogen activator inhibitor 2. Isolation and characterization of the promoter region of the gene. Biochem Biophys Res Commun 156:383, 1988
20. Schuster WA, Medcalf RL, Kruithof EKO: Localization and characterization of a retinoic acid response-like element in the plasminogen activator inhibitor gene promoter. Fibrinolysis 8:113, 1994
21. Antalis TM, Godbolt D, Stringer BW: Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2. Gene 134:201, 1993
22. Minta JO, Pambrun L: In vitro induction of cytologic and functional differentiation of the immature human monocyte-like cell line U-937 with phorbol myristate acetate. Am J Pathol 119:111, 1985
23. Ziegler-Heitbrok HWL, Thiel E, Futterer A, Herzog V, Wirtz A, Reithmuller G: Establishment of a human cell line MonoMac6 with characteristics of mature monocytes. Int J Cancer 41:456, 1988
24. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
25. Henikoff S: Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene 28:351, 1984
26. Ye RD, Ahern SM, Le Beau MM, Lebo RV, Sadler JE: Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin. J Biol Chem 264:5495, 1989
27. Leavitt J, Gunning P, Porreca P, Ng S-Y, Lin C-S, Kedes L: Molecular cloning and characterization of mutant and wild-type human β-actin genes. Mol Cell Biol 4:1961, 1984
28. Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol Cell Biol 2:1044, 1982
29. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanide-phenol-chloroform extraction. Ann Biochem 162:156, 1987
30. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499, 1991
31. Antalis TM, Godbolt D: Isolation of intact nuclei from hematopoietic cell types. Nucleic Acids Res 19:4301, 1991
32. Dickinson J, Antalis TM: Tissue factor and plasminogen activator inhibitor expression in the differentiation of myeloid leukemic cells. Leukemia 7:864, 1993
33. Brand AH, Breeden L, Abraham J, Sternglanz R, Nasmyth K: Characterization of a 'silencer' in yeast: A DNA sequence with properties opposite to those of a transcriptional enhancer. Cell 41:41, 1985
34. Kim S-J, Denhez F, Kim K-Y, Holt JT, Sporn MB, Roberts AB: Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J Biol Chem 264:19373, 1989
35. Weiher H, Konig M, Gruss P: Multiple point mutations affecting the simian virus 40 enhancer. Science 219:626, 1983
36. Payvar, F, DeFranco D, Firestone GL, Edgar B, Wrange O, Okret S, Gustafsson JA, Yamamoto KR: Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 35:381, 1983
37. Baniahmad A, Muller M, Steiner C, Renkawitz R: Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements. EMBO J 6:2297, 1987
38. Cousin E, Medcalf RL, Bergonzelli GE, Kruithof EKO: Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 19:3881, 1991
39. Savagner P, Miyashita T, Yamada Y: Two silencers regulate the tissue-specific expression of the collagen II gene. J Biol Chem 265:6669, 1990
40. Frenkel B, Mijnes J, Aronow MA, Zambetti G, Banerjee C, Stein JL, Lian JB, Stein GS: Postition and orientation-selective silencer in protein coding sequences of the rat osteocalcin gene. Biochemistry 32:13636, 1993
41. Goodbourne S, Burstein H, Maniatis T: The human β-interferon gene enhancer is under negative control. Cell 45:601, 1986
42. Borrelli E, Hen R, Chambon P: Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription. Nature 312:608, 1984
43. Baniahmad A, Steiner C, Kohne AC, Renkawitz R: Modular structure of a chicken lysozyme silencer: Involvement of an unusual thyroid hormone receptor binding site. Cell 61:505, 1990